Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2
Q. Wang, A. Y. Yeh, Y. Guo, H. Mohri, J. Yu, D. D. Ho, L. Liu
This study develops a high-throughput assay to quantify SARS-CoV-2 spike-mediated cell-cell fusion and finds that it is more resistant to antibody inhibition than cell-free infection.
bioRxiv · Mar 9, 2023Microbiology